140 related articles for article (PubMed ID: 27504772)
1. The rise and fall of innovation in biofuels.
Albers SC; Berklund AM; Graff GD
Nat Biotechnol; 2016 Aug; 34(8):814-21. PubMed ID: 27504772
[No Abstract] [Full Text] [Related]
2. Insights into US public biotech sector using patenting trends.
Aggarwal S; Gupta V; Bagchi-Sen S
Nat Biotechnol; 2006 Jun; 24(6):643-51. PubMed ID: 16763590
[TBL] [Abstract][Full Text] [Related]
3. The public-private structure of intellectual property ownership in agricultural biotechnology.
Graff GD; Cullen SE; Bradford KJ; Zilberman D; Bennett AB
Nat Biotechnol; 2003 Sep; 21(9):989-95. PubMed ID: 12949559
[No Abstract] [Full Text] [Related]
4. Biotech patents still strong.
Lawrence S
Nat Biotechnol; 2007 Dec; 25(12):1341. PubMed ID: 18066014
[No Abstract] [Full Text] [Related]
5. Public biotech 2010--the numbers.
Huggett B; Hodgson J; Lähteenmäki R
Nat Biotechnol; 2011 Jul; 29(7):585-91. PubMed ID: 21747381
[No Abstract] [Full Text] [Related]
6. Public biotech 2009-the numbers.
Huggett B; Hodgson J; Lähteenmäki R
Nat Biotechnol; 2010 Aug; 28(8):793-9. PubMed ID: 20697401
[No Abstract] [Full Text] [Related]
7. Public biotechnology 2005--the numbers.
Lähteenmäki R; Lawrence S
Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
[TBL] [Abstract][Full Text] [Related]
8. Public biotechnology 2003-the numbers.
Lähteenmäki R; Baker M
Nat Biotechnol; 2004 Jun; 22(6):665-70. PubMed ID: 15175683
[No Abstract] [Full Text] [Related]
9. Wrong numbers?
Nat Biotechnol; 2010 Aug; 28(8):761. PubMed ID: 20697382
[No Abstract] [Full Text] [Related]
10. Sources of innovation: an assessment of intellectual property.
Kinch MS; Raffo J
Drug Discov Today; 2015 May; 20(5):500-4. PubMed ID: 25499663
[TBL] [Abstract][Full Text] [Related]
11. Public biotech 2006 - the numbers.
Lähteenmäki R; Lawrence S
Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
[No Abstract] [Full Text] [Related]
12. Agbio keeps on growing.
Lawrence S
Nat Biotechnol; 2005 Mar; 23(3):281. PubMed ID: 15765074
[No Abstract] [Full Text] [Related]
13. Public biotech 2007--the numbers.
Lawrence S; Lähteenmäki R
Nat Biotechnol; 2008 Jul; 26(7):753-62. PubMed ID: 18612294
[TBL] [Abstract][Full Text] [Related]
14. The private health sector in India.
Sengupta A; Nundy S
BMJ; 2005 Nov; 331(7526):1157-8. PubMed ID: 16293815
[No Abstract] [Full Text] [Related]
15. Public biotech 2013--the numbers.
Lawrence S; Lahteenmaki R
Nat Biotechnol; 2014 Jul; 32(7):626-32. PubMed ID: 25004227
[No Abstract] [Full Text] [Related]
16. Proportion of private sector spending declining.
Buske L
CMAJ; 2002 Feb; 166(4):498. PubMed ID: 11873937
[No Abstract] [Full Text] [Related]
17. Who will bankroll the next big idea?
Kappas DJ
Sci Am; 2013 Oct; 309(4):58-61. PubMed ID: 24137856
[No Abstract] [Full Text] [Related]
18. Technological innovation in neurosurgery: a quantitative study.
Marcus HJ; Hughes-Hallett A; Kwasnicki RM; Darzi A; Yang GZ; Nandi D
J Neurosurg; 2015 Jul; 123(1):174-81. PubMed ID: 25699414
[TBL] [Abstract][Full Text] [Related]
19. The nature of Asian biopharmaceutical innovation.
Friedman Y
Nat Biotechnol; 2014 Jun; 32(6):523-4. PubMed ID: 24911491
[No Abstract] [Full Text] [Related]
20. Private health insurance coverage--the impact on funding for public health system.
Qld Nurse; 1999; 18(3):22-3. PubMed ID: 12029687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
